Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment. Take 2 mins to learn more.

News & Insights

Dr Heiner Dreismann appointed as Chair of Biofidelity

Heiner is a former executive of Roche Diagnostics AG with more than 35 years of industry experience and a pioneer in the early adoption of polymerase chain reaction (PCR) technology. This appointment follows the completion of a $12m Series A round in 3Q 2020, in which OIC invested £350k.